Medical University of South Carolina
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1955-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.muschealth.com
Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan
Not Applicable
Completed
- Conditions
- Aortic Valve Stenosis
- Interventions
- Drug: Low-volume, low-concentration contrast (iodixanol - Visipaque 270) CT scan
- First Posted Date
- 2013-04-30
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 40
- Registration Number
- NCT01843426
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Intervention to Improve Quality of Life in African American Lupus Patients
Not Applicable
Completed
- Conditions
- DepressionSystemic Lupus Erythematosus
- Interventions
- Behavioral: Chronic Disease Self-Management Program (CDSMP)Behavioral: Mail-delivered arthritis kitBehavioral: Support groupBehavioral: Listserv
- First Posted Date
- 2013-04-23
- Last Posted Date
- 2018-06-15
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 153
- Registration Number
- NCT01837875
- Locations
- 🇺🇸
Institute for Partnerships to Eliminate Health Disparities, University of South Carolina, Columbia, South Carolina, United States
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Not Applicable
Withdrawn
- Conditions
- AnemiaHemorrhage
- Interventions
- Dietary Supplement: Ferrous sulfateDevice: Capsule Endoscopy
- First Posted Date
- 2013-04-22
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Medical University of South Carolina
- Registration Number
- NCT01837030
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Effect of Oxytocin on Craving and Therapy Response
- First Posted Date
- 2013-04-09
- Last Posted Date
- 2017-01-02
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 16
- Registration Number
- NCT01827332
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving
Phase 2
Completed
- Conditions
- Cocaine Addiction
- Interventions
- Drug: PlaceboDrug: Propranolol, 40 mgDrug: Propranolol, 80 mg
- First Posted Date
- 2013-04-02
- Last Posted Date
- 2019-12-26
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 181
- Registration Number
- NCT01822587
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 22
- Registration Number
- NCT01820299
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
Phase 1
Terminated
- Conditions
- Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
- Interventions
- Dietary Supplement: Vitamin D
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2015-07-22
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 1
- Registration Number
- NCT01816555
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Study of Effects of Sildenafil on Patients With Fontan Heart Circulation
Phase 4
Completed
- Conditions
- Single Ventricle Heart Disease After Fontan Surgery
- Interventions
- Diagnostic Test: Cardiac catheterization
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 20
- Registration Number
- NCT01815502
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population
Phase 4
Completed
- Conditions
- Periodontal DiseaseType 2 Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2018-10-04
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 113
- Registration Number
- NCT01798225
Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
Early Phase 1
Terminated
- Conditions
- Adenocarcinoma Pancreas
- Interventions
- Procedure: SurgeryGenetic: Genetic ExpressionDrug: Chemotherapy
- First Posted Date
- 2013-02-04
- Last Posted Date
- 2016-03-08
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 2
- Registration Number
- NCT01783054
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath